InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2022 to Q1 2025

Type / Class
Equity / Common Shares, no par value
Symbol
INM on Nasdaq
Shares outstanding
804,525
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
YA II PN, Ltd. 10% $14,885 80,372 YA II PN, Ltd. 13 Dec 2024

Institutional Holders of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$5 0
2024 Q4 27 $5 -$265,977 $0.19 1
2024 Q3 1,141,865 $265,983 +$152,052 $0.24 12
2024 Q2 440,244 $116,623 -$95,800 $0.27 10
2024 Q1 685,852 $249,191 -$7,375 $0.36 14
2023 Q4 6 $2 -$18,392 $0.33 1
2023 Q3 26,760 $18,461 +$7,234 $0.67 5
2023 Q2 15,610 $14,368 -$91,571 $0.92 5
2023 Q1 100,899 $109,271 -$123,993 $1.08 11
2022 Q4 115,809 $234,131 -$203,650 $2.00 10
2022 Q3 132,974 $876,000 +$876,001 $6.59 7